KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 150 filers reported holding KURA ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,607 | +84.3% | 341 | +113.1% | 0.00% | – |
Q1 2023 | $1,957 | -1.5% | 160 | 0.0% | 0.00% | – |
Q4 2022 | $1,986 | -0.7% | 160 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | – | 160 | +492.6% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 27 | -83.2% | 0.00% | – |
Q3 2021 | $3,000 | +200.0% | 161 | +387.9% | 0.00% | – |
Q2 2021 | $1,000 | -50.0% | 33 | -40.0% | 0.00% | – |
Q1 2021 | $2,000 | -33.3% | 55 | -42.7% | 0.00% | – |
Q4 2020 | $3,000 | – | 96 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |